Dr Maggie Harding (letters, 12 August) does a disservice to women with ovarian cancer. She draws attention to the June Effective Health Care Bulletin on the management of gynaecological cancers, which recommends that Paclitaxel and Carboplatin should be the treatment of choice for this disease. Yet she congratulates health authorities ...